[CLDX] YoY Quarter Result on 30-Sep-2018 [#Q3]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
07-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- 55.85%
YoY- 72.53%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
Revenue 153 668 546 941 3,924 2,220 1,026 -27.15%
PBT -20,679 -14,224 -11,413 -7,243 -31,563 -29,598 -31,980 -7.00%
Tax -227 1,088 -5,090 -14,912 -5,200 -790 -782 -18.61%
NP -20,452 -14,224 -11,413 -7,243 -26,363 -29,598 -31,980 -7.17%
Tax Rate - - - - - - - -
Total Cost 20,605 14,892 11,959 8,184 30,287 31,818 33,006 -7.54%
Ratio Analysis
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
NP Margin -13,367.32 -2,129.34 -2,090.29 -769.71 -671.84 -1,333.24 -3,116.96 27.43%
Per Share
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
EPS -0.45 -0.36 -0.75 -0.66 -3.05 -4.41 -4.87 -32.73%
EPS Diluted -0.45 -0.36 -0.75 -0.66 -3.05 -4.41 -4.87 -32.73%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.